Clinical Trials Directory

Trials / Completed

CompletedNCT00818740

Pharmacokinetic Study of ORM-12741 in Healthy Volunteers

Pharmacokinetics of ORM-12741 After Intravenous and Oral Administration and Effects of Food on ORM-12741 Pharmacokinetics; An Open, Randomised, Single Dose, Single Centre, Crossover Study in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine pharmacokinetic parameters of ORM-12741 in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGORM-12741i.v., oral solution and oral capsule forms. Oral capsule given with and without food.

Timeline

Start date
2009-01-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2009-01-08
Last updated
2009-10-08

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00818740. Inclusion in this directory is not an endorsement.

Pharmacokinetic Study of ORM-12741 in Healthy Volunteers (NCT00818740) · Clinical Trials Directory